Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup

Aug 20,2026 INGENIA

Ingenia Therapeutics Goes Public on KOSDAQ to Accelerate Pipeline of Next-Generation Vascular Antibody Therapeutics

Aug 18,2026 INGENIA

Ingenia Announces First-in-Human Dosing of IGT-303 for CKD/DKD

Nov 21,2025 INGENIA

INGENIA Therapeutics & Nona Biosciences Enter into Collaboration Agreement

Oct 19,2023 INGENIA

INGENIA Therapeutics & Mosaic Biosciences present preclinical data

May 02,2022 INGENIA